The Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) has received a request for updating the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical device covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting properties.
To ensure all relevant scientific information is available to the Scientific Committee for its assessment, SCHEER are holding a consultation.
More information on this consultation can be found here, which closes on 17 July.
